BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ye L, Yan K, Tian Z, Xiao ZH, Xie RY, Xie ZY, Tao L. Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: A large cross-sectional study. World J Gastroenterol 2025; 31(13): 102563 [PMID: 40248064 DOI: 10.3748/wjg.v31.i13.102563]
URL: https://www.wjgnet.com/1007-9327/full/v31/i13/102563.htm
Number Citing Articles
1
Olga V Smirnova, Aleksander A Sinyakov, Edward V Kasparov. <i>Helicobacter pylori</i> infection as a risk factor in the development of metabolic dysfunction-associated steatotic liver diseaseWorld Journal of Hepatology 2025; 17(10): 110833 doi: 10.4254/wjh.v17.i10.110833
2
Meenakshi Kandpal, Tarun Prakash Verma, Siddharth Singh, Hamendra Parmar, Hem Chandra Jha. Metabolomic and lipidomic signatures of Helicobacter pylori infection: Unveiling biochemical pathways associated with neurodegenerationiMetaOmics 2026;  doi: 10.1002/imo2.70088
3
Zhimao Cai, Hualang Cai, Dan Zhou, Zhenzhou Li, Jiashuang Lin, Ye Ye, Sixia Chen, Rourou Li, Mengjia Chen, Yuan Dai, Hui Peng, Weifeng Chen. Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional studyEuropean Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04171-9
4
Fen Wang, Shuo-Yi Yao, Noube Julie Raissa. Relationship between <i>Helicobacter pylori</i> infection and the development of metabolic dysfunction and associated steatotic liver diseaseWorld Journal of Gastroenterology 2025; 31(33): 110176 doi: 10.3748/wjg.v31.i33.110176
5
Han Chen, Yan Wang, Yuting Shao, Wei Su, Shuo Li, Yun Liu, Xiaoying Zhou. Multi‐Omics Analysis Revealed Characterization of Gastric Microbiome and Metabolome in Helicobacter pylori‐Induced Progression of MASLDHelicobacter 2025; 30(5) doi: 10.1111/hel.70069